chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a health professional concerning a 43 year old black female pt with hay fever who on 25-Oct-2002 was vaccinated by subcutaneous injection in the left arm with a dose of measles virus vaccine live and mumps virus vaccine live and rubella virus vaccine live (second generation) (lot number 642498/0345M). On 25-Oct-2002, she developed wheezing, rash to face, and rash to arms. Also the reporter indicated the pt developed shortness of breath apprx. 30 minutes (2:00PM) after the shot.; It was noted the pt was taken to the ER and treated with diphendramine hydrochloride (Benadryl) 50mg PO, famotidine (MSD) 20mg PO and prednisone 60mg PO. Subsequently, on 25-Oct-2002, the pt recovered from wheezing, rash to face, rash to arms, and shortness of breath. It was noted the pt was given a prescription for pradnisone 40 mg, i PO every morning, and famotidine (MSD) 20mg 1 PO every morning. The reporter indicated the pt returned to the employee health department after leaving the ER and had no further shortness of breath or wheezing. Upon internal review, wheezing, and shortness of breath were determined to be an other important medical event. No further information is requested.
Had no symptoms, but had to test before visiting someone in a nursing home. Took a home COVID-19 test and was positive. Rested and waited for it to subside. Still has brain fog, racing heart, shortness of breath and fatigue. Now have Cognitive issues, mainly limited recall memories and worsening speech patterns. Have also developed Incontinence. Has had several coughing fits. Believe it's long COVID-19.
p/vax exp severe (very) on scale 0-10 (worst or unbearable) rated joint pain as 8;pain in 6 joints had injured as a child;also flu-like sx, runny nose, general body & muscle aches, severe h/a, sore throat x 2 days;
Treatment of COVID-19; Treatment of COVID-19; Interchange of vaccine products; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 82-year-old male patient received BNT162b2 (BNT162B2), on 21Aug2021 as dose 3 (booster), single (Lot number: fd8448) and on 22Jul2022 at 13:00 as dose 4 (booster), single (Lot number: fj4991) at the age of 81 years, in left arm for covid-19 immunisation; coviD-19 vaccine nrvv MVa (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), on 20Dec2022 at 13:00 as dose 5 (booster), single (Lot number: a57167b), in left arm for covid-19 immunisation; coviD-19 vaccine nrvv ad (chadox1 ncov-19) (ASTRAZENECA COVID-19 VACCINE), on 05Nov2020 at 11:00 as dose 1, single (Lot number: a03324) and on 03Dec2020 at 10:00 as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "mild diabetes" (unspecified if ongoing); "heart disease" (unspecified if ongoing); "spinal stenosis" (unspecified if ongoing); "known allergies sulfa" (unspecified if ongoing), notes: known allergies sulfa. Concomitant medication(s) included: ATORVASTATIN, start date: Jan2021, stop date: 16Jan2023; OMEPRAZOLE, start date: Jan2022; METOPROLOL TARTRATE, start date: Jan2020; CELECOXIB, start date: 16Nov2022; ASPIRIN [ACETYLSALICYLIC ACID], start date: Jan2018. Past drug history included: Avelox, reaction(s): "known allergies avelox". The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 21Aug2021, outcome "not recovered"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jan2023, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Still testing positive 15 days; Positive. Therapeutic measures were taken as a result of drug ineffective, COVID-19: the patient received Paxlovid from 17Jan2023 to 21Jan2023 for treatment of COVID-19.
When administering the 2nd dose 5/30/21 - and following up on any complications. Patient mentioned getting the first shot higher than normal and needed to take the next day off as the shoulder area hurt and needed to rest it.
Initial information received on 27-Jun-2018 regarding an unsolicited valid non-serious case received from other health professional. This case is linked to cases 2018SA177770, 2018SA177766 and 2018SA177772. This case involves a patient (age reported as 16-20 years, gender not reported) who experienced redness, swelling and lump at injection site, while she received vaccine [ADACEL]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. It was reported that the patient did not receive any other vaccine on the date of administration. On 18-Jun-2018, the patient received a dose of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (lot C5541AA, expiry date: 13-Nov-2020) via intramuscular route in the deltoid nos. On an unknown date, the patient developed a non-serious redness, swelling and lump at injection site, following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE. Relevant tests were not reported. Final diagnosis was lump at injection site and redness, swelling at injection site. It was not reported if the patient received a corrective treatment. The outcome of the events was not reported. List of documents held by sender: none.
Patient presents with ? Sore Throat     x 2 days ? Earache     right ? Headache ? Fatigue ? Cough
reported numbness in lt arm from inject site down, starting 4NOV; reported on 13NOV persistent sensory problems requiring hosp admission to hosp;
Low grade fever, nausea, vomiting diarrhea, body aches, chills, fatigue
Patient reported fever 99.0-100.0F.  Had a reported rash on body.  "Few spots on Sunday and more on Monday."
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. Concurrent conditions, medical history and allergies were not reported. On an unknown date, the unspecified number of patients were vaccinated with doses of (Oka/Merck) VARIVAX, (dose, frequency, route, anatomical location, lot number and expiration date were not reported), which were improperly stored. No adverse effects were reported and no product quality complaint (PQC) was filled. Follow up information has been received on 07-APR-2015, it was reported that the freezer in which the vaccines were stored went through "an auto defrost". There were no adverse events. On the same day 07-APR-2015, follow-up information has been received from Healthcare worker who provided patients' identifiers. This report refers to a 16 year old patient, who on 05-MAR-2015, was vaccinated with improperly stored dose of (Oka/Merck) VARIVAX, 0.5 ml (route was not reported), lot number as K011801, exp. date: 21-AUG-2016. This is one of several reports received from the same source. Additional information has been requested.
bump in vaccination arm/ bump where the vaccination was; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced injection site swelling. On an unknown date, the outcome of the injection site swelling was not recovered/not resolved.   It was unknown if the reporter considered the injection site swelling to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received dose of Shingrix a month ago from  the date of reporting and experienced bump at the injection site. The patient stated that, was reluctant to get the follow up vaccine, but the bump has not diminished in the month since the initial vaccination.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2, Vaccine brand unknown, Vaccine lot unknown, Vaccine dose number unknown-False), on 07Apr2022 at 10:00 as dose 4 (booster), single (Lot number: FK2587) at the age of 73 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "mild hypertension" (unspecified if ongoing); "Penicillin and derivatives" (unspecified if ongoing), notes: Known allergies: Penicillin and derivatives. Concomitant medication(s) included: AMLODIPINE, start date: Apr2018. Past drug history included: Valacyclovir, reaction(s): "Known allergies: Valacyclovir". The following information was reported: DRUG INEFFECTIVE (medically significant) with onset 17Jul2022, outcome "unknown", COVID-19 (medically significant) with onset 17Jul2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 antibody test: (17Jul2022) Positive, notes: Tested positive for COVID on 17Jul2022; (24Jul2022) Negative, notes: Tested negative on 24Jul2022 and 28Jul2022; (28Jul2022) Negative, notes: Tested negative on 24Jul2022 and 28Jul2022; (31Jul2022) Positive, notes: Retested positive on the Antigen Rapid Test at home test on 31Jul2022; (01Aug2022) Positive, notes: tested positive again on 01Aug2022. Therapeutic measures were taken as a result of drug ineffective, covid-19. Anti-viral details: Product-COVID 19 Treatment, Brand-Paxlovid, Treatment start date-17Jul2022, Treatment stop date-22Jul2022, Lot number-28156213, Indication-Treatment of COVID-19 (Adverse event: Tested positive for COVID on 17Jul2022 with cold-like symptoms and started Paxlovid that evening. Completed Paxlovid on 22Jul2022 with symptoms completely resolved. Tested negative on 24Jul2022 and 28Jul2022 using iHealth COVID-19 Antigen Rapid Test at home. On 31Jul2022 experienced severe lethargy, but no fever or other symptoms, and suspected COVID on the rebound. Retested positive on the Antigen Rapid Test at home test on 31Jul2022. Though asymptomatic at that point, tested positive again on 01Aug2022. Returned to isolation. Other medication details: Other medication in 2 weeks product-Amlodipine 5mg, Other medication in 2 weeks brand-Generic, Other medication in 2 weeks start date-Apr2018).  No follow-up attempts are possible. No further information is expected.
Early the next morning after the vaccine I woke up to my whole arm swollen with a very itchy rash that was down the whole arm.  I was nauseated and ran a temp that never elevated over 101.  I was super sleepy and tired.  The lymph nodes under my are swole preventing me from getting my Mammogram until July.  My Dr did a physical inspection and advised to keep it clean and take tylenol to help with the disconfort
pt recv vax 30SEP98 & noted onset of extreme fatigue, nausea gen joint pain (large & small), dec appetite starting 4OCT98;sx remained until 16OCT98;
chills, localized rxn or redness & swelling;tx w/hot packs & Ibuprofen;
4 hours after taking shot developed temperature of 106, severe headache and nausea. after taking generic Tylenol after 2 hours temperature went back to normal and headache and nausea went away.
Over the course of 24-48 hours:  Chills for 8 hours, tired for 24 hours,  aches for 15 hours until I took ibuprofen, headache for 6 hours until ibuprofen taken
Pt experienced pain at immunization site. Two hours later followed by muscle and joint pain in arm. Two hours after that joint and muscle pain spread to neck, back, abdomen and arms. Pt experienced muscle spasms and pain for 7 weeks. Pt developed a knot and pain at injection site lasting for 1 week.
Patient states she woke up in the middle of the night and she was shaking like she was having a convulsion. Her legs were straight and she was shaking very hard. It happened 4 times that night. She thinks she may have had a low grade fever, but she didn't take her temperature. It has not happened since, but she feels like she has had brain fog since that time.
a friend did Pfizer and now has a skin condition, an autoimmune problem, that cannot be out in the sun anymore because of Pfizer.; a friend did Pfizer and now has a skin condition, an autoimmune problem, that cannot be out in the sun anymore because of Pfizer.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: AUTOIMMUNE DISORDER (medically significant), PHOTOSENSITIVITY REACTION (medically significant), outcome "unknown" and all described as "a friend did Pfizer and now has a skin condition, an autoimmune problem, that cannot be out in the sun anymore because of Pfizer.".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Red hives 12/8/01 left shoulder, upper arm and shoulder, across back and lower back, back of neck,around both eyes were red also. Ref. to mom to take child to Prompt care.
CHILLS; NAUSEA; FEVER; INJECTION SITE PAIN; This spontaneous report received from a patient concerned a 71 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802072 expiry: UNKNOWN) dose was not reported, administered on 07-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 08-MAR-2021, the subject experienced injection site pain. On 20-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.2 F. On 20-MAR-2021 05:00, the subject experienced chills. On 20-MAR-2021 05:00, the subject experienced nausea. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site pain on MAR-2021, and had not recovered from chills, fever, and nausea. This report was non-serious.
I believe on 11/27 I started developing flu-like symptoms. Headache, feeling hot, congestion and developed a cough. On 11/29 I had a different medical event that I emailed my doctor, and they scheduled me to come in. I went in on 11/30 and still had my flu-like symptoms so they tested me for COVID-19, flu, and strep throat. In the parking lot I received the notification that I had contracted both strains of the flu. The office called me to advise on medications and isolating. Later on my COVID-19 results came back as positive as well, another call from my doctor. Later that day I also tested positive for strep throat. They prescribed antibiotics, said bed rest, water, isolation, and OTC for symptoms. I tested negative for COVID-19 twice on 12/9. Still dealing with some congestion but it feels like everything else is better.
Fever 103.3, joint and body aches, headache, fatigue, swelling , pain and redness at injection site
pt recvd vax & devel large area of redness & swelling which were hot to the touch on the arm following vax;
Zoey began being nauseous and vomiting on August 10. We have taken her to the PCP 2 times for the vomiting and the gastroenterologist. She vomits each day 2-7 times, has lost 12 pounds in 20 days, headaches and dehydration. There is currently no official diagnosis and the treatments are on going.
Vaccine administered on 5/22/19. On 5/28/19 the pt called the office to report pain in Left arm. Denied redness or warmth. The patient stated that she had a co-worked look at the injection site and it was noted to be two fingerbreadths below the top of the arm. The patient saw her PCP on 5/28/19 and the PCP reports that injection was given directly into Deltoid Bursa. Patient diagnosed with bursitis. Patient instructed to immobilize and ice extremity. Patient started physical therapy on 10/7/2019.  Discharged from physical therapy on 12/27/2019
Injection site was "normally" sore for 1 day. Say after arm (below injection site & not at the site of injection) became sore. Sore for 4 days with inflammation & redness. Recovered by fifth day & no problem thereafter.
No AEs; RN called to report temperature excursion that occurred on 7/12/2022. Caller states that 100 doses of PROQUAD and 94 doses of VARIVAX were administered since 7/12/2022 from mobile unit to children in community. No further information provided. No add; This spontaneous report was received from a nurse and refers a child of unknown gender. The patients' concurrent conditions, medical history, allergies and concomitant therapies were not reported.  On 12-JUL-2022, 40 doses of the vaccine varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U029621with expiration date 20-SEP-2023) 0.5 ml once underwent a temperature excursion during storage.   On an unknown date, the patient was one of 40 patients vaccinated with vaccine varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U029621, expiration date 20-SEP-2023) administered as prophylaxis (dose regimen details were not provided).   No adverse event was reported. No further information was reported.  This is one of several reports received from the same reporter.
My right arm became week and I was having tremors in my right hand and my hand was weak, I couldn't really grip very strongly. This happen on the way home, so it was within an hour or so after I got the shot. I went to my physical therapist the next day (for my left shoulder not connected to vaccine) and he was testing my strength in both arms my right arm had about half as much as my left. I am right handed and am a very strong woman so this was very unusual for me. I did get my flu shot in my right arm because my left shoulder was already hurting. I then started experiencing severe night sweats which I had never in my life before. This went for around 2-3 weeks several nights per week. I have had a complete hysterectomy and I am on daily hormones and have been on the same ones for years so I am not and will never go through menopause. Just as suddenly as they started the night seats just stopped. But I continue to have weakness in my arm and hand, the tremors in my hand are better but are still there and I mean all the time not just every once in awhile. It almost feels like my arm and hand had a stroke. Everything else is fine.
I obviously didn't know I was just a few days pregnant at the time of my work-required flu shot. (Date of last period was Sept. 15, conception somewhere the first week of October.) In late October I found out I was pregnant. Just days after finding out, I started spotting and cramping. I spotted a little with my first child so I wasn?t immediately alarmed. I just kept my 8-week appointment as scheduled. The bleeding increased so I called Dr. who ordered a blood test that day and ultrasound the next morning. Blood test showed an HCG level of around 4,000 and we were planning a follow-up blood draw at the end the next day. I went to the ultrasound the next morning and within 20 minutes my doctor called to have me come in right away. The ultrasound showed a small mass in my tube. The doctor was willing to let me wait for the follow-up blood test, but said if I had any pain, to go to the emergency department because if the tube ruptured, I was at high risk of bleeding to death. That night the pain became severe so my husband and I headed to the ED. Within an hour I was in surgery to remove the ectopic pregnancy.   My first pregnancy had no complications whatsoever and I had no risk factors for having an ectopic pregnancy. Even in line to get the flu shot I told I co-worker I was nervous to get the shot because I had seen the study where you are more likely to miscarry if you get consecutive flu shots, which I?m required to do for work. She knew we were trying for our second child.  I know it?s hard to prove that the shot caused the loss, but the dates work out and I have no other reason to have had complications.
Day 1 - Extreme weakness, dizziness, nausea.  Could not eat and limited intake of fluids. Injection site felt like it was burning along with a very sizable lump. Could not get out of bed for more than 15 minutes at a time. Day 2 - Still extremely weak.  Dizziness not as bad. Still no appetite. Still spent most of the day in bed asleep.
PNEUMOVAX injection given 10/6/2008 on 10/8/2008 right arm erythematous macular areas of varying sizes, oval shaped max 3cm. No induration of ecchymosis. Lesions not at site of injection.
A 14 year old female faints approximately 3 minutes after the vaccine is administered. The patient was evaluated, vital signs B/P 70/50, pulse 86, Resp. 16, Dextro 96mg/dl. Doctor is consulted, who indicates that she is placed on a stretcher with raised legs, oral fluids are replenished with "GATORADE" and that in 30 minutes vitals be re evaluated. At 30 min vitals are reassessed B/P 100/60, Pulse 96, Res 18, patient reports feeling well and without discomfort. To which doctor is consulted and indicates that he can withdraw from the vaccination center. Patient leaves walking on own feet.
feb 26th: muscle pain, joint pain, whole-body rash treatment: steroid cream, zyrtec, tylenol outcome: ongoing
Patient hospitalized on 4/27/2021 for bilateral renal artery stenosis. Patient hospitalized on 5/11/2021 for AAA greater than 5.0 cm. These visits are within 6 weeks of receiving COVID vaccination. Patient had second dose of vaccine on 5/5/2021.
Local hives, ascending on both arms. Administered 50mg Benadryl PO. Monitored for 15 minutes. When leaving facility LVN reports hives minimizing. No complaints for patient
the patient was given a fluzone at the 2 month visit by mistake.  the only thing the parent has noticed is that the patient has developed a cough
9/10/21 pt dc'd from hosp after hypoxic respiratory failure; 9/11/21 pt back to the hosp with confusion and hypoxia from SNF; pt was removing BiPAP in SNF and O2 sats were 71%; admitted with chronic hypoxic respiratory failure; placed on 4L via NC; elevated WBC; placed on BiPAP; CXR showed pneumonia pattern; given antibiotic; candidemia; given antifungal regime; pt experienced asystole, code blue called, CPR done; pt is a DNI; ROSC achieved for a brief period but oxygenation was poor; pt passed away in the hospital
MODERN 0.5 ML FOR IM LOT 015M20A EPX:07/31/2021 No known adverse events.
PATIENT REPORTED ON MARCH 31TH EXPERIENCING SEVERE MUSCLE PAIN AND BODY ACHES SINCE THE NEXT DAY AFTER RECEIVEING HER FIST MODERNA COVID-19 VACCINE DOSE ON MARCH 20TH 2021.  PATIENT RECEIVED CARE FROM HER PCP AND WAS PRESCRIBED TYLENOL 325MG.  HOWEVER, THE MEDICATION HAD NO EFFECT OF RELEIVING HER DISCOMFORT.  SHE WAS ADVISED TO FOLLOW UP WITH HER PCP TO RECEIVE ADDITIONAL CARE.  PATIENT DID REPORT SHE HAD A SIMILAR EXPERIENCE IN OCT 2020 THAT LASTED A MONTH.
730AM on 27AUG98 fine, light, rash on cheeks & chin gradually spread throughout day to shoulders, upper arms & chest;no fever;a little grumpy;eats ok;